These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 20360048)

  • 1. The siRNA sequence and guide strand overhangs are determinants of in vivo duration of silencing.
    Strapps WR; Pickering V; Muiru GT; Rice J; Orsborn S; Polisky BA; Sachs A; Bartz SR
    Nucleic Acids Res; 2010 Aug; 38(14):4788-97. PubMed ID: 20360048
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of asymmetric terminal structures of short RNA duplexes on the RNA interference activity and strand selection.
    Sano M; Sierant M; Miyagishi M; Nakanishi M; Takagi Y; Sutou S
    Nucleic Acids Res; 2008 Oct; 36(18):5812-21. PubMed ID: 18782830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Competition for RISC binding predicts in vitro potency of siRNA.
    Koller E; Propp S; Murray H; Lima W; Bhat B; Prakash TP; Allerson CR; Swayze EE; Marcusson EG; Dean NM
    Nucleic Acids Res; 2006; 34(16):4467-76. PubMed ID: 16945958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis of nuclease-resistant siRNAs possessing universal overhangs.
    Ueno Y; Watanabe Y; Shibata A; Yoshikawa K; Takano T; Kohara M; Kitade Y
    Bioorg Med Chem; 2009 Mar; 17(5):1974-81. PubMed ID: 19200743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deep Sequencing Analyses of DsiRNAs Reveal the Influence of 3' Terminal Overhangs on Dicing Polarity, Strand Selectivity, and RNA Editing of siRNAs.
    Zhou J; Song MS; Jacobi AM; Behlke MA; Wu X; Rossi JJ
    Mol Ther Nucleic Acids; 2012 Apr; 1(4):e17. PubMed ID: 23343928
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in silencing of mismatched targets by sliced versus diced siRNAs.
    Sun G; Wang J; Huang Y; Yuan CW; Zhang K; Hu S; Chen L; Lin RJ; Yen Y; Riggs AD
    Nucleic Acids Res; 2018 Jul; 46(13):6806-6822. PubMed ID: 29718312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of acyclic nucleoside modifications in siRNAs finds sensitivity at position 1 that is restored by 5'-terminal phosphorylation both in vitro and in vivo.
    Kenski DM; Cooper AJ; Li JJ; Willingham AT; Haringsma HJ; Young TA; Kuklin NA; Jones JJ; Cancilla MT; McMasters DR; Mathur M; Sachs AB; Flanagan WM
    Nucleic Acids Res; 2010 Jan; 38(2):660-71. PubMed ID: 19917641
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity.
    Bramsen JB; Laursen MB; Nielsen AF; Hansen TB; Bus C; Langkjaer N; Babu BR; Højland T; Abramov M; Van Aerschot A; Odadzic D; Smicius R; Haas J; Andree C; Barman J; Wenska M; Srivastava P; Zhou C; Honcharenko D; Hess S; Müller E; Bobkov GV; Mikhailov SN; Fava E; Meyer TF; Chattopadhyaya J; Zerial M; Engels JW; Herdewijn P; Wengel J; Kjems J
    Nucleic Acids Res; 2009 May; 37(9):2867-81. PubMed ID: 19282453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational design and in vitro and in vivo delivery of Dicer substrate siRNA.
    Amarzguioui M; Lundberg P; Cantin E; Hagstrom J; Behlke MA; Rossi JJ
    Nat Protoc; 2006; 1(2):508-17. PubMed ID: 17406276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional dissection of siRNA sequence by systematic DNA substitution: modified siRNA with a DNA seed arm is a powerful tool for mammalian gene silencing with significantly reduced off-target effect.
    Ui-Tei K; Naito Y; Zenno S; Nishi K; Yamato K; Takahashi F; Juni A; Saigo K
    Nucleic Acids Res; 2008 Apr; 36(7):2136-51. PubMed ID: 18267968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells.
    Czauderna F; Fechtner M; Dames S; Aygün H; Klippel A; Pronk GJ; Giese K; Kaufmann J
    Nucleic Acids Res; 2003 Jun; 31(11):2705-16. PubMed ID: 12771196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene-silencing properties of siRNAs that contain internal amide-bond linkages.
    Gong W; Desaulniers JP
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6934-7. PubMed ID: 23062704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of siRNA with an asymmetric RNA/dTdT overhang on RNA interference activity.
    Park JH; Hong SW; Yun S; Lee DK; Shin C
    Nucleic Acid Ther; 2014 Oct; 24(5):364-71. PubMed ID: 25211666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of siRNA nuclease stability on the in vitro and in vivo kinetics of siRNA-mediated gene silencing.
    Bartlett DW; Davis ME
    Biotechnol Bioeng; 2007 Jul; 97(4):909-21. PubMed ID: 17154307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular basis for improved gene silencing by Dicer substrate interfering RNA compared with other siRNA variants.
    Snead NM; Wu X; Li A; Cui Q; Sakurai K; Burnett JC; Rossi JJ
    Nucleic Acids Res; 2013 Jul; 41(12):6209-21. PubMed ID: 23620279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cheminformatics Modeling of Gene Silencing for Both Natural and Chemically Modified siRNAs.
    Dong X; Zheng W
    Molecules; 2022 Sep; 27(19):. PubMed ID: 36234948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RNA interference-mediated gene silencing of pleiotrophin through polyethylenimine-complexed small interfering RNAs in vivo exerts antitumoral effects in glioblastoma xenografts.
    Grzelinski M; Urban-Klein B; Martens T; Lamszus K; Bakowsky U; Höbel S; Czubayko F; Aigner A
    Hum Gene Ther; 2006 Jul; 17(7):751-66. PubMed ID: 16839274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Competition potency of siRNA is specified by the 5'-half sequence of the guide strand.
    Yoo JW; Kim S; Lee DK
    Biochem Biophys Res Commun; 2008 Feb; 367(1):78-83. PubMed ID: 18164261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical modifications on siRNAs avoid Toll-like-receptor-mediated activation of the hepatic immune system in vivo and in vitro.
    Broering R; Real CI; John MJ; Jahn-Hofmann K; Ickenstein LM; Kleinehr K; Paul A; Gibbert K; Dittmer U; Gerken G; Schlaak JF
    Int Immunol; 2014 Jan; 26(1):35-46. PubMed ID: 24065781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved silencing properties using small internally segmented interfering RNAs.
    Bramsen JB; Laursen MB; Damgaard CK; Lena SW; Babu BR; Wengel J; Kjems J
    Nucleic Acids Res; 2007; 35(17):5886-97. PubMed ID: 17726057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.